Oxford Symposia


Antisense & Therapeutic Nucleic Acids

30 March 2015, St Edmund Hall, Oxford, UK

Twitter: @LPMHealthcare, #OligoOxford

Welcome to OLIGO 2015 Oxford

We are delighted to announce our first Oxford Symposium on antisense and therapeutic oligonucleotides. 

The symposium is aimed at bringing together chemists and biologists from academia and industry to discuss the latest advances and breakthroughs in the development of synthetic oligonucleotides as therapeutics. We hope this symposium will form the foundations of an annual gathering of oligonucleotide researchers at Oxford.

The symposium agenda is currently in progress. We invite proposal for oral presentations, in particular on THERAPEUTIC APPLICATIONS AND DELIVERY STRATEGIES of synthetic oligonucleotides, including:

>Antisense oligonucloetides
>Chemical modifications
>Toxicity and pharmacokinetics
>Delivery strategies

Keynote Speakers

BrownProfessor Tom Brown
Professor of Nucleic Acid Chemistry
Department of Chemistry and Oncology
University of Oxford, UK
Title: Click nucleic acid ligation: Chemistry and Applications

GaitDr Mike Gait
Group Leader
Medical Research Council
Laboratory of Molecular Biology, Cambridge, UK
Title: Peptide-PMO conjugates for antisense treatment of neuromuscular diseases

Please contact us on OLIGOMER@LPMHealthcare.com, with your presentation theme, or if you have any questions.

The Symposium will be co-hosted with our 2nd annual aptamer symposium and exhibition, Aptamers 2015.